-transparent.png){kind=logo}
A pan-sarbecovirus vaccine induces highly potent and durable neutralizing antibody responses in non-human primates against SARS-CoV-2 Omicron variant. 2022
Zezhong Liu, and
Jasper Fuk-Woo Chan, and
Jie Zhou, and
Meiyu Wang, and
Qian Wang, and
Guangxu Zhang, and
Wei Xu, and
Kenn Ka-Heng Chik, and
Yilong Zhang, and
Youchun Wang, and
Kwok-Yung Yuen, and
Lu Lu, and
Shibo Jiang
Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Frontiers Science Center of Pathogenic Microbes and Infection, Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
Related Publications
Zezhong Liu, and
Jasper Fuk-Woo Chan, and
Jie Zhou, and
Meiyu Wang, and
Qian Wang, and
Guangxu Zhang, and
Wei Xu, and
Kenn Ka-Heng Chik, and
Yilong Zhang, and
Youchun Wang, and
Kwok-Yung Yuen, and
Lu Lu, and
Shibo Jiang
March 2023,
Proceedings of the National Academy of Sciences of the United States of America,
Zezhong Liu, and
Jasper Fuk-Woo Chan, and
Jie Zhou, and
Meiyu Wang, and
Qian Wang, and
Guangxu Zhang, and
Wei Xu, and
Kenn Ka-Heng Chik, and
Yilong Zhang, and
Youchun Wang, and
Kwok-Yung Yuen, and
Lu Lu, and
Shibo Jiang
April 2023,
Cell reports,
Zezhong Liu, and
Jasper Fuk-Woo Chan, and
Jie Zhou, and
Meiyu Wang, and
Qian Wang, and
Guangxu Zhang, and
Wei Xu, and
Kenn Ka-Heng Chik, and
Yilong Zhang, and
Youchun Wang, and
Kwok-Yung Yuen, and
Lu Lu, and
Shibo Jiang
May 2022,
Proceedings of the National Academy of Sciences of the United States of America,
Zezhong Liu, and
Jasper Fuk-Woo Chan, and
Jie Zhou, and
Meiyu Wang, and
Qian Wang, and
Guangxu Zhang, and
Wei Xu, and
Kenn Ka-Heng Chik, and
Yilong Zhang, and
Youchun Wang, and
Kwok-Yung Yuen, and
Lu Lu, and
Shibo Jiang
April 2022,
ACS infectious diseases,
Zezhong Liu, and
Jasper Fuk-Woo Chan, and
Jie Zhou, and
Meiyu Wang, and
Qian Wang, and
Guangxu Zhang, and
Wei Xu, and
Kenn Ka-Heng Chik, and
Yilong Zhang, and
Youchun Wang, and
Kwok-Yung Yuen, and
Lu Lu, and
Shibo Jiang
December 2022,
Emerging microbes & infections,
Zezhong Liu, and
Jasper Fuk-Woo Chan, and
Jie Zhou, and
Meiyu Wang, and
Qian Wang, and
Guangxu Zhang, and
Wei Xu, and
Kenn Ka-Heng Chik, and
Yilong Zhang, and
Youchun Wang, and
Kwok-Yung Yuen, and
Lu Lu, and
Shibo Jiang
March 2022,
Cell,
Zezhong Liu, and
Jasper Fuk-Woo Chan, and
Jie Zhou, and
Meiyu Wang, and
Qian Wang, and
Guangxu Zhang, and
Wei Xu, and
Kenn Ka-Heng Chik, and
Yilong Zhang, and
Youchun Wang, and
Kwok-Yung Yuen, and
Lu Lu, and
Shibo Jiang
July 2022,
Cell reports. Medicine,
Zezhong Liu, and
Jasper Fuk-Woo Chan, and
Jie Zhou, and
Meiyu Wang, and
Qian Wang, and
Guangxu Zhang, and
Wei Xu, and
Kenn Ka-Heng Chik, and
Yilong Zhang, and
Youchun Wang, and
Kwok-Yung Yuen, and
Lu Lu, and
Shibo Jiang
November 2020,
Signal transduction and targeted therapy,
Zezhong Liu, and
Jasper Fuk-Woo Chan, and
Jie Zhou, and
Meiyu Wang, and
Qian Wang, and
Guangxu Zhang, and
Wei Xu, and
Kenn Ka-Heng Chik, and
Yilong Zhang, and
Youchun Wang, and
Kwok-Yung Yuen, and
Lu Lu, and
Shibo Jiang
January 2023,
Access microbiology,
Zezhong Liu, and
Jasper Fuk-Woo Chan, and
Jie Zhou, and
Meiyu Wang, and
Qian Wang, and
Guangxu Zhang, and
Wei Xu, and
Kenn Ka-Heng Chik, and
Yilong Zhang, and
Youchun Wang, and
Kwok-Yung Yuen, and
Lu Lu, and
Shibo Jiang
January 2022,
Signal transduction and targeted therapy,
